279 related articles for article (PubMed ID: 24517621)
1. Juvenile idiopathic arthritis: updated guide to administering methotrexate.
Livermore P
Nurs Child Young People; 2014 Feb; 26(1):26-9. PubMed ID: 24517621
[TBL] [Abstract][Full Text] [Related]
2. The use of methotrexate in children with rheumatic diseases.
Gutiérrez-Suárez R; Burgos-Vargas R
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
[TBL] [Abstract][Full Text] [Related]
3. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.
Ravelli A; Moretti C; Temporini F; Rossi F; Magni-Manzoni S; Pistorio A; Martini A
Clin Exp Rheumatol; 2002; 20(4):569-72. PubMed ID: 12175118
[TBL] [Abstract][Full Text] [Related]
5. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
[TBL] [Abstract][Full Text] [Related]
6. Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay.
Möhlmann JE; de Roock S; Egas AC; Weijden ET; Doeleman MJH; Huitema ADR; van Luin M; Swart JF
Pediatr Rheumatol Online J; 2024 May; 22(1):52. PubMed ID: 38715014
[TBL] [Abstract][Full Text] [Related]
7. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
Roszkiewicz J; Smolewska E
Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the use of methotrexate in juvenile idiopathic arthritis.
Niehues T; Lankisch P
Paediatr Drugs; 2006; 8(6):347-56. PubMed ID: 17154642
[TBL] [Abstract][Full Text] [Related]
10. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.
Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W
Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602
[TBL] [Abstract][Full Text] [Related]
11. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis.
de Rotte MC; Bulatovic M; Heijstek MW; Jansen G; Heil SG; van Schaik RH; Wulffraat NM; de Jonge R
J Rheumatol; 2012 Oct; 39(10):2032-40. PubMed ID: 22859359
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy.
Lahdenne P; Rapola J; Ylijoki H; Haapasaari J
J Rheumatol; 2002 Nov; 29(11):2442-5. PubMed ID: 12415606
[TBL] [Abstract][Full Text] [Related]
13. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
van Dijkhuizen EH; Wulffraat NM
Pediatr Rheumatol Online J; 2014; 12():51. PubMed ID: 25525416
[TBL] [Abstract][Full Text] [Related]
14. Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis.
Pohjankoski H; Kautiainen H; Lauri JV; Puolakka K; Rantalaiho V
Clin Rheumatol; 2020 Jan; 39(1):263-268. PubMed ID: 31346886
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
Niehues T; Horneff G; Michels H; Höck MS; Schuchmann L; ;
Rheumatol Int; 2005 Apr; 25(3):169-78. PubMed ID: 15688190
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop?
Foell D; Frosch M; Schulze zur Wiesch A; Vogl T; Sorg C; Roth J
Ann Rheum Dis; 2004 Feb; 63(2):206-8. PubMed ID: 14722212
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate.
Alexeeva E; Dvoryakovskaya T; Denisova R; Sleptsova T; Isaeva K; Chomahidze A; Fetisova A; Mamutova A; Alshevskaya A; Gladkikh V; Moskalev A
Pediatr Neonatol; 2019 Oct; 60(5):549-555. PubMed ID: 30885783
[TBL] [Abstract][Full Text] [Related]
18. Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey.
Amin TS; Shenton S; Mulligan K; Wedderburn LR; Wood M; VanRooyen V; Leone V
Rheumatology (Oxford); 2015 Nov; 54(11):2108-9. PubMed ID: 26209331
[No Abstract] [Full Text] [Related]
19. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.
Ferrara G; Mastrangelo G; Barone P; La Torre F; Martino S; Pappagallo G; Ravelli A; Taddio A; Zulian F; Cimaz R;
Pediatr Rheumatol Online J; 2018 Jul; 16(1):46. PubMed ID: 29996864
[TBL] [Abstract][Full Text] [Related]
20. Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
Horton DB; Onel KB; Beukelman T; Ringold S
J Rheumatol; 2017 Mar; 44(3):352-360. PubMed ID: 28148696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
